| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Classified under Biotechnology (Health Care sector), AVBP's insider flows are most useful compared with peers in the same group.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| 10% | 3.93M | $91.82M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec 10, 2025 | Hillhouse Investment Management, Ltd. | 10% Owner | Sell | 555,555 | $23.37 | $12,983,320.35 | -12.4% | +4.0% | - | |
| Jan 30, 2024 | Orbimed Advisors LLC68 | Director, 10% Owner | Buy | 444,444 | $18.00 | $7,999,992.00 | +41.6% | -25.7% | +31.9% | |
| Jan 30, 2024 | Gordon Carl L74 | Director, 10% Owner | Buy | 444,444 | $18.00 | $7,999,992.00 | +41.6% | -25.7% | +31.9% | |
| Jan 30, 2024 | Healy James | Director | Buy | 444,444 | $18.00 | $7,999,992.00 | +35.5% | -25.7% | +31.9% | |
| Jan 30, 2024 | Hillhouse Investment Management, Ltd. | 10% Owner | Buy | 555,555 | $18.00 | $9,999,990.00 | +14.1% | -25.7% | +31.9% |